Works matching IS 10538569 AND DT 2018 AND VI 27 AND IP 3
Results: 18
Cover Image.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. i, doi. 10.1002/pds.4425
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 1, doi. 10.1002/pds.4628
- Publication type:
- Article
Erratum.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 356, doi. 10.1002/pds.4414
- Publication type:
- Article
Do FDA label changes work? Assessment of the 2010 class label change for proton pump inhibitors using the Sentinel System's analytic tools.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 332, doi. 10.1002/pds.4392
- By:
- Publication type:
- Article
Exceeding the daily dosing limit of nonsteroidal anti‐inflammatory drugs among ibuprofen users.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 322, doi. 10.1002/pds.4391
- By:
- Publication type:
- Article
Drug adherence in treatment resistant and in controlled hypertension—Results from the Swedish Primary Care Cardiovascular Database (SPCCD).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 315, doi. 10.1002/pds.4388
- By:
- Publication type:
- Article
Bias from restricting to live births when estimating effects of prescription drug use on pregnancy complications: A simulation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 307, doi. 10.1002/pds.4387
- By:
- Publication type:
- Article
A systematic assessment of key design and performance characteristics of drug exposure registries requested by the U.S. Food and Drug Administration.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 299, doi. 10.1002/pds.4386
- By:
- Publication type:
- Article
Relevance of frailty to mortality associated with the use of antipsychotics among community‐residing older adults with impaired cognition.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 289, doi. 10.1002/pds.4385
- By:
- Publication type:
- Article
Use of antihypertensive drugs and risk of keratinocyte carcinoma: A meta‐analysis of observational studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 279, doi. 10.1002/pds.4384
- By:
- Publication type:
- Article
Risk of rhabdomyolysis from 5‐α reductase inhibitors.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 351, doi. 10.1002/pds.4383
- By:
- Publication type:
- Article
Beta testing the potential link between the alpha antagonist tamsulosin and dementia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 349, doi. 10.1002/pds.4382
- By:
- Publication type:
- Article
Strengthening standards, transparency, and collaboration to support medicine evaluation: Ten years of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP).
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 245, doi. 10.1002/pds.4381
- By:
- Publication type:
- Article
Risk factors for medication errors at admission in preoperatively screened patients.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 272, doi. 10.1002/pds.4380
- By:
- Publication type:
- Article
Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 263, doi. 10.1002/pds.4375
- By:
- Publication type:
- Article
Assessment of Risk Evaluation and Mitigation Strategies (REMS) for varenicline (Chantix): A multistage patient survey.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 253, doi. 10.1002/pds.4373
- By:
- Publication type:
- Article
Tamsulosin and the risk of dementia in older men with benign prostatic hyperplasia.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 340, doi. 10.1002/pds.4361
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2018, v. 27, n. 3, p. 357, doi. 10.1002/pds.4309
- Publication type:
- Article